Skip to content

Homeopathic treatment of paralysis after stroke

Efficacy of Individualized Homoeopathic Medicines in the Treatment of Post-Stroke Hemiparesis: An Open, Randomized, Placebo-Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016196
Enrollment
60
Registered
2018-10-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I693- Sequelae of cerebral infarction

Interventions

Intervention1: Individualized homeopathic medicines in centesimal and 50 millesimal potencies: Intervention is planned as administering indicated homoeopathic medicines in centesimal or 50 millesimal
16 doses to be marked on the vial
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 m

Sponsors

National Institute Of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases suffering from Post-stroke Hemiparesis consistently for more than 3 months 2. Both male and female patients 3. Age 35- 70 years 4. Ability to read English and/or Bengali 5. Capability and willingness to give informed consent and to comply with the study protocol

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study and denying consent 2. Hemiparesis due to causes other than stroke 3. Patients with psychiatric disorders 4. Pregnant or lactating women 5. Self-reported immune-compromised state 6. Substance abuse and/or dependence 7. Cases suffering from uncontrolled systemic illness or life-threatening infections or any vital organ failure 8. Cases already undergoing homeopathic treatment for any chronic disease within eight weeks prior to enrolment

Design outcomes

Primary

MeasureTime frame
Medical Research Councils muscle strength grading scale (MRC muscle scale)Timepoint: At baseline and after 3 months

Secondary

MeasureTime frame
Modified Ashworth Scale (MAS) measuring muscle spasticityTimepoint: At baseline and after 3 months;Stroke Impact Scale (SIS) version 2.0Timepoint: At baseline and after 3 months

Countries

India

Contacts

Public ContactSubhas Singh

National Institute of Homoeopathy

drssubhas@gmail.com9830644223

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 13, 2026